Sepracor goes live with allergy website

Marlborough drug maker Sepracor Inc. has powered up a new website on allergies only days after announcing the availability of a new prescription nasal spray for allergy sufferers.

Omnaris Nasal Spray is indicated for the treatment of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older as well as for symptoms associated with perennial allergic rhinitis in adults and adolescents 12 years of age and older, the company said.

Meanwhile, Sepracor said today that it has launched a "My Allergies in America" website, which contains data drawn from a survey of people with allergic rhinitis, including information about how people with rhinitis can better manage their allergies.

An estimated 40 million people in the United States are affected by allergic rhinitis, noted Sepracor, which is perhaps best known for its Lunesta insomnia drug.
(By Chris Reidy, Globe staff)